Mesirow Financial Investment Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Mesirow Financial Investment Management’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,633	Closed	-$190K	–	91
2022 Q3	$190K	Buy	+17,633	New	+$200K	0.9%	66
2021 Q2	–	Sell	-753	Closed	-$8K	–	139
2021 Q1	$8K	Buy	753 +322	+75%	+$3.67K	0.02%	135
2020 Q4	$3.46K	Buy	+431	New	+$3.39K	0.01%	126
2020 Q3	–	Sell	-19,780	Closed	-$179K	–	79
2020 Q2	$179K	Sell	19,780 -436	-2%	-$4.52K	0.84%	69
2020 Q1	$194K	Buy	+20,216	New	+$242K	1.22%	54

Other funds holding OPNT

WSL

Western Standard LLC Los Angeles, California $295M AUM 40.98% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NYLIM

New York Life Investment Management New York $14.3B AUM 34.42% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Ramius Advisors New York $95.2M AUM 7.33% 1-Year Est. Return

Mesirow Financial Investment Management's OPNT Position: Q4 2022 in Review

Mesirow Financial Investment Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q4 2022, closing a stake of 17,633 shares — an estimated $190K sold.

Mesirow Financial Investment Management first reported a position in OPNT in Q1 2020 and held it in 5 quarters. The position peaked at $194K in Q1 2020. 37 funds tracked by Wall St. Rank hold OPNT as of Q4 2022.

Mesirow Financial Investment Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Mesirow Financial Investment Management sold 17,633 Opiant Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $190K.
Mesirow Financial Investment Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 5 quarters.
Mesirow Financial Investment Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $194K in Q1 2020.
37 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Mesirow Financial Investment Management's 13F filing for Q4 2022, filed 19 Jan 2023.